×

Merck's 'check point' therapy for cancer

7:32 AM ET Mon, 6 June 2016

CNBC's Meg Tirrell talks with Merck's Roger Perlmutter about advances the drugmaker has made in treating cancer, including immunotherapy drug KEYTRUDA. Perlmutter also addresses concerns over the high price of drugs.